
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Oncology Today with Dr Neil Love
00:00
Comparing zanubrutinib and acalabrutinib
Tam reviews available data, pharmacokinetics and subtle safety differences between zanubrutinib and acalabrutinib.
Play episode from 19:11
Transcript


